Gene · 5903
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature. | Front Oncol | 2023 | 37305584 | PubTator, text mining | PubMed |
| Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia. | Hemasphere | 2023 | 37304931 | PubTator, text mining | PubMed |
| Integrated multi-omics for rapid rare disease diagnosis on a national scale. | Nat Med | 2023 | 37291213 | PubTator, text mining | PubMed |
| Acute Necrotizing Encephalitis Due to Influenza B in a Child: A Case Report. | Cureus | 2023 | 37288218 | PubTator, text mining | PubMed |
| HIV-1 capsid stability enables inositol phosphate-independent infection of target cells and promotes integration into genes. | PLoS Pathog | 2023 | 37267431 | PubTator, text mining | PubMed |
| The m6A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m6A-Dependent Manner. | Pharmaceuticals (Basel) | 2023 | 37259333 | PubTator, text mining | PubMed |
| A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome. | Front Neurol | 2023 | 37251223 | PubTator, text mining | PubMed |
| Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic. | J Biol Chem | 2023 | 37247759 | PubTator, text mining | PubMed |
| You Shall Not Pass: MX2 Proteins Are Versatile Viral Inhibitors. | Vaccines (Basel) | 2023 | 37243034 | PubTator, text mining | PubMed |
| Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | Mol Syst Biol | 2023 | 37219487 | PubTator, text mining | PubMed |
| Cellular gp96 upregulates AFP expression by blocking NR5A2 SUMOylation and ubiquitination in hepatocellular carcinoma. | J Mol Cell Biol | 2023 | 37204028 | PubTator, text mining | PubMed |
| Cisplatin-Resistant Ovarian Cancer Cells Reveal a Polyploid Phenotype with Remarkable Activation of Nuclear Processes. | Adv Biomed Res | 2023 | 37200756 | PubTator, text mining | PubMed |
| Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy. | Genet Med | 2023 | 37191094 | PubTator, text mining | PubMed |
| Tandem detergent-extraction and immunoprecipitation of proteinopathy: Scalable enrichment of ALS-associated TDP-43 aggregates. | iScience | 2023 | 37182104 | PubTator, text mining | PubMed |
| Inflammatory myofibroblastic tumor of the urinary bladder with FN1‑ALK gene fusion: A case report. | Oncol Lett | 2023 | 37153035 | PubTator, text mining | PubMed |
| Microtubule acetylation dyshomeostasis in Parkinson's disease. | Transl Neurodegener | 2023 | 37150812 | PubTator, text mining | PubMed |
| Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. | MedComm (2020) | 2023 | 37143582 | PubTator, text mining | PubMed |
| The interactions between PML nuclear bodies and small and medium size DNA viruses. | Virol J | 2023 | 37127643 | PubTator, text mining | PubMed |
| SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma. | Front Cell Dev Biol | 2023 | 37123398 | PubTator, text mining | PubMed |
| Neurological Adverse Reactions to SARS-CoV-2 Vaccines. | Clin Psychopharmacol Neurosci | 2023 | 37119215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5903/papers?page=13